Figures and Tables

From the following article:

Drug Insight: antiangiogenic therapies for gastrointestinal cancers—focus on monoclonal antibodies

Anke Reinacher-Schick, Michael Pohl and Wolff Schmiegel

Nature Clinical Practice Gastroenterology & Hepatology (2008) 5, 250-267
doi:10.1038/ncpgasthep1097

BACK TO ARTICLE
Figure 1 - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, or to obtain a text description, please contact npg@nature.com

Figure 1

Mechanistic view of antiangiogenic therapy.

Full size and legend (36K)Download PowerPoint slide (94K)
Figure 2 - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, or to obtain a text description, please contact npg@nature.com

Figure 2

Roles of VEGF and DLL4 in the regulation of tumor angiogenesis.

Full size and legend (32K)Download PowerPoint slide (82K)
Table 1 - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, or to obtain a text description, please contact npg@nature.com

Table 1

Examples of antiangiogenic agents currently under investigation.

Full size and legend Download PowerPoint slide (142K)
Table 2 - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, or to obtain a text description, please contact npg@nature.com

Table 2

Examples of recent trials with the VEGF-specific antibody bevacizumab.

Full size and legend Download PowerPoint slide (119K)
BACK TO ARTICLE